Insys Therapeutics Company Description
Insys Therapeutics can soothe your stomach and make the pain go away. The company focuses on developing drugs for treating nausea and vomiting resulting from chemotherapy, as well as pain management and other central nervous conditions. Its Dronabinol HG product candidate, a generic capsule form of Marinol awaiting FDA approval, treats chemotherapy patients who do not respond to traditional treatments. Insys Therapeutics also produces inhalation and room temperature capsule and syrup forms of its Dronabinol drug. In addition, the company's Fentanyl SL spray product, delivered under the tongue for quick absorption, provides treatment for pain in cancer patients.
View the Comprehensive Company Description for Insys Therapeutics
The Company Description provides a historical perspective of Insys Therapeutics's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Insys Therapeutics's evolution in the marketplace.
